Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors

Authors

Institutions

Publication Details

Journal
Oncology and Therapy
Published
2025-05-14
DOI
https://doi.org/10.1007/s40487-025-00340-8
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors

Jan H.M. Schellens, Alwin D. R. Huitema, Sybrand W J Zielhuis, Hilde Rosing et al.
Oncology and Therapy
Cancer Genomics and Diagnostics
article

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors

Jan H.M. Schellens, Alwin D. R. Huitema, Sybrand W J Zielhuis, Hilde Rosing, Ruud van der Noll, David S. Boss, Jos H. Beijnen, Merel J J Lucassen, Neeltje Steeghs, Matthijs M. Tibben, Daphne W M Voogd
article en

Abstract

No abstract available for this paper.
Oncology and TherapyVol. 13(2)
Utrecht University (NL), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), Oncode Institute (NL), Princess Máxima Center (NL)
Pharmaceuticals Bayer
Good health and well-being
Openalex Percentile: Top 86%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.